Metabonomic analysis of serum of workers occupationally exposed to arsenic, cadmium and lead for biomarker research: A preliminary study

Environment International

Volumn 68, Issue , 2014, Pages 71-81

  Dudka, Ilona ^a   Kossowska, Barbara ^b   Senhadri, Hanna ^a   Latajka, Rafał ^a   Hajek, Julianna ^a   Andrzejak, Ryszard ^b   Antonowicz Juchniewicz, Jolanta ^b   Gancarz, Roman ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Environmental toxicology; Heavy metals; Metabolomics; Metabonomics; Molecular epidemiology; Pattern recognition

Indexed keywords

AMINO ACIDS; ARSENIC; BIOMARKERS; BODY FLUIDS; CADMIUM; DIAGNOSIS; HEAVY METALS; LIPOPROTEINS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATTERN RECOGNITION; PRINCIPAL COMPONENT ANALYSIS;

ENVIRONMENTAL TOXICOLOGY; LOW DENSITY LIPOPROTEINS; METABOLOMICS; METABONOMIC ANALYSIS; METABONOMICS; MOLECULAR EPIDEMIOLOGY; PARTIAL LEAST SQUARES - DISCRIMINANT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

METABOLISM;

ARSENIC; CADMIUM; LEAD; LOW DENSITY LIPOPROTEIN; UNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

AMINO ACID; ARSENIC; BIOMARKER; CADMIUM; DISCRIMINANT ANALYSIS; EPIDEMIOLOGY; HEALTH RISK; HEAVY METAL; LEAD; LEAST SQUARES METHOD; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; PATTERN RECOGNITION; PUBLIC HEALTH; SERUM; TOXICOLOGY;

ADULT; AMINO ACID METABOLISM; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; ENERGY METABOLISM; HUMAN; LEAD BLOOD LEVEL; LIPID ANALYSIS; LIPID METABOLISM; MALE; METABOLITE; METABOLOME; METABOLOMICS; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SMELTER;

ENVIRONMENTAL TOXICOLOGY; HEAVY METALS; METABOLOMICS; METABONOMICS; MOLECULAR EPIDEMIOLOGY; PATTERN RECOGNITION;

AMINO ACIDS; ARSENIC; BIOLOGICAL MARKERS; CADMIUM; DISCRIMINANT ANALYSIS; ENERGY METABOLISM; FATTY ACIDS, UNSATURATED; HUMANS; LEAD; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; METABOLOMICS; OCCUPATIONAL EXPOSURE; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84897474015     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2014.03.015     Document Type: Article

References (81)

1. 1H NMR spectroscopy of human blood plasma. Prog Nucl Magn Reson Spectrosc 1997, 27:475-554.
2. Ala-Korpela, Kangas A., Soininen P. Quantitative high-throughput metabolomics: a new era in epidemiology and genetics. Genome Med 2012, 4(4):36.
3. Antti H., Ebbels T.M.D., Keun H.C., Bollard M.E., Beckonert O., Lindon J.C., et al. Statistical experimental design and partial least squares regression analysis of biofluid metabonomic NMR and clinical chemistry data for screening of adverse drug effects. Chemometr Intell Lab Syst 2004, 73:139-149.
4. ASTM Standard E178-08 Standard practice for dealing with outlying observations 2008, ASTM International.
5. 1H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. Int J Epidemiol 2008, 37(Suppl. 1):i31-i40.
6. Blanchet L., Smolinska A., Attali A., Stoop M.P., Ampt K.A., van Aken H., et al. Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics 2011, 12:254.
7. Bonvallot N., Tremblay-Franco M., Chevrier C., Canlet C., Warembourg C., Cravedi J.P., et al. Metabolomics tools for describing complex pesticide exposure in pregnant women in Brittany (France). PLoS One 2013, 8(5):e64433.
8. Brodsky L., Moussaieff A., Shahaf N., Aharoni A., Rogachev I. Evaluation of peak picking quality in LC-MS metabolomics data. Anal Chem 2010, 82(22):9177-9187. 10.1021/ac101216e.
9. Cattell R. The scree test for the number of factors. Multivar Behav Res 1966, 1(2):245-276.
10. Clarke C.J., Haselden J.N. Metabolic profiling as a tool for understanding mechanisms of toxicity. Toxicol Pathol 2008, 36(1):140-147.
11. Consonni V., Ballabio D., Todeschini R. Comments on the definition of the Q2 parameter for QSAR validation. J Chem Inf Model 2009, 49(7):1669-1678.
12. Consonni V., Ballabio D., Todeschini R. Evaluation of model predictive ability by external validation techniques. J Chemometr 2010, 24(3-4):194-201.
13. de Burbure C., Buchet J.P., Leroyer A., Nisse C., Haguenoer J.M., Mutti A., et al. Renal and neurologic effect of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 2006, 114(4):584-590.
14. Diz A.P., Truebano M., Skibinski D.O.F. The consequences of sample pooling in proteomics: an empirical study. Electrophoresis 2009, 30:2967-2975.
15. Dunteman G.H. Principal components analysis. Chapter: using principal components to detect outlying and influential observations 1989, Sage Publications, Newbury Park.
16. Ellis J.K., Athersuch T.J., Cavill R., Radford R., Slattery C., Jennings P., et al. Metabolic response to low-level toxicant exposure in a novel renal tubule epithelial cell system. Mol Biosyst 2011, 7(1):247-257. 10.1039/c0mb00146e.
17. Ellis J.K., Athersuch T.J., Thomas L.D.K., Teichert F., Pérez-Trujillo M., Svendsen C., et al. Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population. BMC Med 2012, 10:61.
18. Everitt B., Hothorn T. An introduction to applied multivariate analysis with R 2011.
19. 1H NMR-based metabonomic approach. J Nutr 2007, 137(4):923-929.
20. 3. Anal Biochem 2002, 301(1):1-7.
21. Garçon G., Leleu B., Marez T., Zerimech F., Haguenoer J.M., Furon D., et al. Biomonitoring of the adverse effects induced by the chronic exposure to lead and cadmium on kidney function: usefulness of alpha-glutathione S-transferase. Sci Total Environ 2007, 377(2-3):165-172.
22. Gerszten R.E., Wang T.J. The search for new cardiovascular biomarkers. Nature 2008, 451(7181):949-952.
23. Griffin J.L. Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Curr Opin Chem Biol 2003, 7(5):648-654.
24. Griffin J.L., Walker L.A., Troke J., Osborn D., Shore R.F., Nicholson J.K. The initial pathogenesis of cadmium induced renal toxicity. FEBS Lett 2000, 478(1-2):147-150.
25. Griffin J.L., Walker L.A., Shore R.F., Nicholson J.K. Metabolic profiling of chronic cadmium exposure in the rat. Chem Res Toxicol 2001, 14(10):1428-1434.
26. 1H NMR spectroscopy studies on the renal biochemistry in the bank vole (Clethrionomys glareolus) and the effects of arsenic (As3+) toxicity. Xenobiotica 2001, 31(6):377-385.
27. Harezlak J., Wu M.C., Wang M., Schwartzman A., Christiani D.C., Lin X. Biomarker discovery for arsenic exposure using functional data. Analysis and feature learning of mass spectrometry proteomic data. J Proteome Res 2008, 7(1):217-224.
28. Hebels D.G., Georgiadis P., Keun H.C., Athersuch T.J., Vineis P., Vermeulen R., et al. Performance in omics analyses of blood samples in long-term storage: opportunities for the exploitation of existing biobanks in environmental health research. Environ Health Perspect 2013, 121(4):480-487.
29. Ho J.E., Larson M.G., Vasan R.S., Ghorbani A., Cheng S., Rhee E.P., et al. Metabolite profiles during oral glucose challenge. Diabetes 2013, 62(8):2689-2698.
30. Hochadel J.F., Waalkes M.P. Sequence of exposure to cadmium and arsenic determines to extent of toxic effects in male Fischer rats. Toxicology 1997, 116(1-3):89-98.
31. Holmes E., Loo R.L., Stamler J., Bictash M., Yap I.K., Chan Q., et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453(7193):396-400.
32. Hong F., Jin T., Zhang A. Risk assessment on renal dysfunction caused by co-exposure to arsenic and cadmium using benchmark dose calculation in a Chinese population. Biometals 2004, 17(5):573-580.
33. Hu H., Shine J., Wright R.O. The challenge posed to children's health by mixtures of toxic waste: the Tar Creek superfund site as a case-study. Pediatr Clin North Am 2007, 54(1):155-175.
34. Jaremek M., Yu Z., Mangino M., Mittelstrass K., Prehn C., Singmann P., et al. Alcohol-induced metabolomic differences in humans. Transl Psychiatry 2013, 3:e276.
35. Johnson C.H., Gonzalez F.J. Challenges and opportunities of metabolomics. J Cell Physiol 2012, 227:2975-2981.
36. Kaiser H. A revised measure of sampling adequacy for factor-analytic data matrices. Educ Psychol Meas 1981, 41(2):379-381.
37. Kaiser H.F. The varimax criterion for analytic rotation in factor analysis. Psychometrika 1958, 23(3):187-200.
38. Karp N.A., Lilley K.S. Investigating sample pooling strategies for DIGE experiments to address biological variability. Proteomics 2009, 9:388-397.
39. 1H NMR) in rats. Toxicol Appl Pharmacol 2010, 249(2):114-126.
40. Klawitter J., Rivard C.J., Brown L.M., Capasso J.M., Almeida N.E., Maunsbach A.B.., et al. A metabonomic and proteomic analysis of changes in IMCD3 cells chronically adapted to hypertonicity. Nephron Physiol 2008, 109(1):1-10.
41. Kossowska B., Dudka I., Bugla-Płoskońska G., Szymańska-Chabowska A., Doroszkiewicz W., Gancarz R., et al. Proteomic analysis of serum of workers occupationally exposed to arsenic, cadmium, and lead for biomarker research: a preliminary study. Sci Total Environ 2010, 408:5317-5324.
42. Kossowska B., Dudka I., Gancarz R., Antonowicz-Juchniewicz J. Application of classic epidemiological studies and proteomics in research of occupational and environmental exposure to lead, cadmium and arsenic. Int J Hyg Environ Health 2013, 216(1):1-7. 10.1016/j.ijheh.2012.03.002.
43. Kuhn M., Kuhn M. Building predictive models in R using the caret package. J Stat Softw 2008, 28(5).
44. Lei R., Wu C., Yang B., Ma H., Shi C., Wang Q., et al. Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity. Toxicol Appl Pharmacol 2008, 232:292-301.
45. 1H NMR spectroscopy. Anal Biochem 2007, 364(2):112-121.
46. Lindon J.C., Holmes E., Bollard M.E., Stanley E.G., Nicholson J.K. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004, 9(1):1-31.
47. Liu M.L., Nicholson J.K., Parkinson J.A., Lindon J.C. Measurement of biomolecular diffusion coefficients in blood plasma using two-dimensional 1H-1H diffusion-edited total-correlation NMR spectroscopy. Analytical Chemistry 1997, 69:1504-1509.
48. Liu J., Liu Y., Habeebu S.M., Waalkes M.P., Klaassen C.D. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice. Toxicology 2000, 147(3):157-166.
49. Luque-Garcia J.L., Cabezas-Sanchez P., Camara C. Proteomics as a tool for examining of heavy metals. Trends Anal Chem 2011, 30(5):703-716.
50. Mamas M., Dunn W.B., Neyses L., Goodacre R. The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 2011, 85(1):5-17. 10.1007/s00204-010-0609-6.
51. Muñoz B., Albores A. The role of molecular biology in the biomonitoring of human exposure to chemicals. Int J Mol Sci 2010, 11(11):4511-4525.
52. Navas-Acien A., Selvin E., Sharrett A.R., Calderon-Aranda E., Silbergeld E., Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterialdisease. Circulation 2004, 109(25):3196-3201.
53. 13C NMR Spectroscopy of Human Blood Plasma. Anal Chem 1995, 67(5):793-811.
54. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
55. Oberbach A., Blüher M., Wirth H., Till H., Kovacs P., Kullnick Y., et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 2011, 10(10):4769-4788.
56. O'Sullivan A., Gibney M.J., Brennan L. Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 2011, 93(2):314-321.
57. Pinto J., Domingues M.R., Galhano E., Pita C., Almeida Mdo C., Carreira I.M., et al. Human plasma stability during handling and storage: impact on NMR metabolomics. Analyst 2014, 139(5):1168-1177.
58. Poreba R., Poreba M., Gać P., Pilecki W., Andrzejak R. Impaired endothelial function assessed by flow-mediated vasodilatation in workers occupationally exposed to lead. Environ Toxicol Pharmacol 2010, 29(3):266-270.
59. Poreba R., Gać P., Poreba M., Antonowicz-Juchniewicz J., Andrzejak R. Relation between occupational exposure to lead, cadmium, arsenic and concentration of cystatin C. Toxicology 2011, 283(2-3):88-95.
60. Poreba R., Gać P., Poreba M., Antonowicz-Juchniewicz J., Andrzejak R. Relationship between occupational exposure to lead and local arterial stiffness and left ventricular diastolic function in individuals with arterial hypertension. Toxicol Appl Pharmacol 2011, 254(3):342-348.
61. R Development Core Team R: a language and environment for statistical computing 2009, 409. R Foundation for Statistical Computing, Vienna, Austria.
62. Rappaport S.M., Smith M.T. Environment and disease risks. Science 2010, 330:460.
63. Robertson D.G., Watkins P.B., Reily M.D. Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci 2011, 120:S146-S170.
64. Schirra H.J., Anderson C.G., Wilson W.J., Kerr L., Craik D.J., Waters M.J., et al. Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study. PLoS One 2008, 3(7):e2764.
65. Silins I., Högberg J. Combined toxic exposures and human health: biomarkers of exposure and effect. Int J Environ Res Public Health 2011, 8(3):629-647.
66. Smolinska A., Blanchet L., Buydens L.M., Wijmenga S.S. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 2012, 750:82-97.
67. Soininen P., Kangas A.J., Würtz P., Tukiainen T., Tynkkynen T., Laatikainen R., et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst 2009, 134(9):1781-1785.
68. Tang H., Wang Y., Nicholson J.K., Lindon J.C. Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Anal Biochem 2004, 325(2):260-272.
69. Telaar A., Nürnberg G., Repsilber D. Finding biomarker signatures in pooled sample designs: a simulation framework for methodological comparisons. Adv Bioinforma 2010, 318573.
70. Tripathi S., Somashekar B.S., Mahdi A.A., Gupta A., Mahdi F., Mahdi H., et al. Aluminum-mediated metabolic changes in rat serum and urine: a proton nuclear magnetic resonance study. J Biochem Mol Toxicol 2008, 22(2):119-127.
71. Vineis P., Khan A.E., Vlaanderen J., Vermeulen R. The impact of new research technologies on our understanding of environmental causes of disease: the concept of clinical vulnerability. Environ Health 2009, 8:54.
72. Vlaanderen J., Moore L.E., Smith M.T., Lan Q., Zhang L., Skibola C.F., et al. Application of omics technologies in occupational and environmental health research; current status and projections. Occup Environ Med 2010, 67(2):136-143.
73. Wang G., Fowler B.A. Role of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol Appl Pharmacol 2008, 233(1):92-99.
74. Wang K.C., Kuo C.H., Tian T.F., Tsai M.H., Chiung Y.M., et al. Metabolomic characterization of laborers exposed to welding fumes. Chem Res Toxicol 2012, 25(3):676-686.
75. Waring J.F., Jolly R.A., Ciurlionis R., Lum P.Y., Praestgaard J.T., Morfitt D.C. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 2001, 175(1):28-42.
76. Wei L., Liao P., Wu H., Li X., Pei F., Li W., et al. Toxicological effects of cinnabar in rats by NMR base metabolic profiling of urine and serum. Toxicol Appl Pharmacol 2008, 227:417-429.
77. 1H NMR spectroscopy. Toxicol Appl Pharmacol 2009, 234:314-325.
78. Wishart D.S., Knox C., Guo A.C., Eisner R., Young N., Gautam B., et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009, 37:D603-D610. [Database issue].
79. Witten D., Tibshirani R. A comparison of fold-change and the t-statistic for microarray data analysis. Tech rep. Department of Statistics, Stanford University technical report 2007.
80. Xu T., Holzapfel C., Dong X., Bader E., Yu Z., Prehn C., et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med 2013, 11:60.
81. Zhai R., Su S., Lu X., Liao R., Ge X., He M., et al. Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers. Biometals 2005, 18(6):603-613.